
    
      This is a phase I, pilot, open, randomized, parallel, and cross-over trial to assess the
      interaction between three different dose levels of sunitinib (50 mg, 37.5 mg, and 25 mg) and
      two dose levels of ketoconazole (200 mg and 400 mg) in 12 healthy volunteers (6 voluunteers
      in each group of treatment) Each volunteer will be assigned to a treatment arm (Arm A and Arm
      B. Volunteers included in Arm A will take: sunitinib 50 mg, sunitinib 37.5 mg + ketoconazole
      200 mg and sunitinib 37.5 mg + 400 mg ketoconazole. Volunteers included in Arm B will take:
      sunitinib 50 mg, sunitinib 25 mg + ketoconazole 200 mg and sunitinib 25 mg + 400 mg
      ketoconazole
    
  